Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5288522
Max Phase: Preclinical
Molecular Formula: C55H58N6Na6O21S6
Molecular Weight: 1325.44
Associated Items:
ID: ALA5288522
Max Phase: Preclinical
Molecular Formula: C55H58N6Na6O21S6
Molecular Weight: 1325.44
Associated Items:
Canonical SMILES: CC(C)(C)c1cc(Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)ccc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3ccc(Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)cc3C(C)(C)C)c2)c1.[NaH].[NaH].[NaH].[NaH].[NaH].[NaH]
Standard InChI: InChI=1S/C55H52N6O21S6.6Na.6H/c1-54(2,3)39-23-33(56-43-17-19-45(85(71,72)73)37-25-35(83(65,66)67)27-47(49(37)43)87(77,78)79)13-15-41(39)60-51(62)29-9-7-11-31(21-29)58-53(64)59-32-12-8-10-30(22-32)52(63)61-42-16-14-34(24-40(42)55(4,5)6)57-44-18-20-46(86(74,75)76)38-26-36(84(68,69)70)28-48(50(38)44)88(80,81)82;;;;;;;;;;;;/h7-28,56-57H,1-6H3,(H,60,62)(H,61,63)(H2,58,59,64)(H,65,66,67)(H,68,69,70)(H,71,72,73)(H,74,75,76)(H,77,78,79)(H,80,81,82);;;;;;;;;;;;
Standard InChI Key: BMVVVIFXRFKRAA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1325.44 | Molecular Weight (Monoisotopic): 1324.1510 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Fu K, Bai Z, Chen L, Ye W, Wang M, Hu J, Liu C, Zhou W.. (2020) Antitumor activity and structure-activity relationship of heparanase inhibitors: Recent advances., 193 [PMID:32222663] [10.1016/j.ejmech.2020.112221] |
Source(1):